Skip to main content

I AM IGHID: Sandy Barnhart

September 28, 2022
IGHID is the engine that drives UNC’s global health research, in a culture that both inspires and unites people who are working to solve global health problems. Sandy Barnhart is known for her multiple skills and contributions to grant management, and she’s passionate about IGHID’s purpose. 1) What do you do as...

Don’t miss IGHID Fest! Pathways to Global Health Research

September 26, 2022
IGHID is the research engine that drives UNC’s global health work, attracting investigators and collaborators who work together on four continents, in a reciprocal exchange of education and practice. We invite you to learn more about our organization during UNC Research Week.  IGHID Fest! will take place October 11-13. Please...

Wohl, Fischer Study Long Ebola Symptoms Which May Help Explain Long COVID

September 21, 2022
Survivors of the Ebola outbreak in 2014 report a wide range of lingering symptoms that include fatigue and muscle pain, as well as neurological issues. But not much has been known about the persistence and severity of the symptoms over time. Investigators from the Institute for Global Health & Infectious...

Study Demonstrates Black and Hispanic People in NC Have Highest Risk of Dying at Home Due to COVID-19

September 16, 2022
COVID-19 has become a leading cause of death and reduced life expectancy in the U.S., especially among Black and Latino populations. David Wohl, MD, member of the Institute for Global Health & Infectious Diseases and professor of medicine in infectious diseases, and first author Jessie Edwards, PhD, assistant professor in the...

Cohen Featured in NOVA Program “Ending HIV in America” Premiering October 5 at 9 pm on PBS

September 14, 2022
(Note: This post has been updated to reflect a schedule change.) Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Myron “Mike” Cohen, MD, director of...

Wahl Receives $3.2 Million to Study the Neurological Consequences of HIV Infection

September 7, 2022
Angela Wahl, PhD, a member of the Institute for Global Health & Infectious Diseases (IGHID), the International Center for the Advancement for Translational Science, and assistant professor in the division of infectious diseases has received a $3.2 million R01 award to study the role of microglia in HIV latency and...

Bringing Global to North Carolina

August 29, 2022
In a hospital, ambulance or a remote village in sub-Saharan Africa, researchers are focused on improving pregnancy outcomes with access to high-quality obstetric ultrasound, when and where it’s needed. Each year some 300,000 women and 3 million babies worldwide die during childbirth or shortly thereafter, according to the World Health Organization,...

Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa

August 23, 2022
Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million...

UNC Receives $17 Million to Develop AI-Enabled Obstetric Ultrasound

August 22, 2022
UNC-Chapel Hill has received a $17 million grant from the Bill & Melinda Gates Foundation to continue groundbreaking work in artificial intelligence (AI)-enabled obstetric ultrasound. CHAPEL HILL, NC – The new award will support an interdisciplinary team from the UNC School of Medicine and Gillings School of Global Public Health,...

Shekinah Elmore’s Road to Radiation Oncology Was Long, Exhausting, and Unexpected

August 15, 2022
When Shekinah Elmore started medical school in 2010, she approached it with a mindset uncharacteristic of most first-year students: To do her best, and if her best wasn’t good enough, then that was okay. “I think the overachiever types who often go to med school are very afraid of failure,”...

Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda

August 13, 2022
In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of terrain that might make for a beautiful and strenuous weekend hike for visitors but not necessarily for the people who live...

I AM IGHID: Joelle Howard

August 12, 2022
Regulatory Affairs (RA) plays a critical role throughout the grant lifecycle, ensuring protocol integrity in the development of drugs and vaccines on the path to human use. Joelle Howard, who goes by Jo, joined IGHID last June. She is one of three regulatory document specialists who work across departments, schools,...

IGHID Investigators Discuss Projects As New Academic Year Begins

August 12, 2022
Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations....

Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

August 8, 2022
Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article,...

Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

August 8, 2022
Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in...

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 1, 2022
Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through...

CDC renews five-year funding for vector-borne disease threats

July 25, 2022
The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in...

Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

June 24, 2022
Recently published in eBioMedicine, this study represents the work of the late Professor Steve Meshnick who served as mentor to Andreea Waltmann, a postdoctoral scholar with the Institute for Global Health & Infectious Diseases. Dr. Meshnick died August 5, 2020.  Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers...

Driven to make big change: spotlighting IGHID’s Global HIV Prevention and Treatment Clinical Trials Unit (CTU)

June 15, 2022
Infectious disease research at the UNC Institute for Global Health and Infectious Diseases (IGHID) attracts unique people driven to make big change in the world. As HIV/AIDS turned 40 in 2021, the world was immersed in a different pandemic, one that brought reminders of the tremendous change science made possible...

NIAID recognizes HPTN’s groundbreaking work in covid prevention tools

June 9, 2022
The 2022 HPTN Annual Meeting took place June 5-8 in Washington, D.C., bringing hundreds of worldwide researchers, collaborators, community representatives, and government health officials together to share updates and accomplishments and re-engage with each other as a community. HPTN Principal Investigators Myron Cohen, MD, director of the UNC Institute for...